Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026)
Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-1.52 Mn |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
2.17 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
-7.36 Mn |
| 10 |
Relmada Therapeutics |
581.07 Mn |
581.07 Mn |
- |
11.37 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
11.37 Mn |
| Dec 31, 2025 |
12.26 Mn |
| Sep 30, 2025 |
6.29 Mn |
| Jun 30, 2025 |
7.40 Mn |
| Mar 31, 2025 |
6.27 Mn |
| Dec 31, 2024 |
8.08 Mn |
| Sep 30, 2024 |
11.86 Mn |
| Jun 30, 2024 |
8.10 Mn |
| Mar 31, 2024 |
9.68 Mn |
| Dec 31, 2023 |
12.08 Mn |
| Sep 30, 2023 |
12.24 Mn |
| Jun 30, 2023 |
12.29 Mn |
| Mar 31, 2023 |
12.29 Mn |
| Dec 31, 2022 |
11.83 Mn |
| Sep 30, 2022 |
8.21 Mn |
| Jun 30, 2022 |
14.60 Mn |
| Mar 31, 2022 |
13.28 Mn |
| Dec 31, 2021 |
8.91 Mn |
| Sep 30, 2021 |
8.66 Mn |
| Jun 30, 2021 |
9.13 Mn |
